TCL Archive Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction. April 21, 2006
TCL Archive Cancer Care Cost To Jump by 27 Percent In a Decade, Reaching $158 Billion in 2020 January 28, 2011
TCL Archive ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards? November 8, 2002
